tiprankstipranks
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
4577
Daito Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4577 full AI Analyst Report?

Daito Pharmaceutical Co., Ltd. (4577) Financial Statements

0 Followers

Daito Pharmaceutical Co., Ltd. Financial Overview

Daito Pharmaceutical Co., Ltd.'s market cap is currently ¥37.88B. The company's EPS TTM is ¥99.39; its P/E ratio is 12.10; and it has a dividend yield of 2.75%. Daito Pharmaceutical Co., Ltd. is scheduled to report earnings on July 10, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
May 25May 24May 23May 22May 21
Income Statement
Total Revenue¥ 50.65B¥ 50.64B¥ 46.90B¥ 45.10B¥ 43.46B
Gross Profit¥ 9.90B¥ 8.47B¥ 9.67B¥ 10.15B¥ 11.31B
Operating Income¥ 3.64B¥ 2.62B¥ 3.89B¥ 5.21B¥ 6.57B
EBITDA¥ 8.02B¥ 7.41B¥ 7.92B¥ 8.96B¥ 10.04B
Net Income¥ 3.16B¥ 1.91B¥ 3.29B¥ 3.60B¥ 4.67B
Balance Sheet
Cash & Short-Term Investments¥ 954.00M¥ 2.21B¥ 2.73B¥ 3.61B¥ 4.38B
Total Assets¥ 73.29B¥ 78.00B¥ 77.71B¥ 70.55B¥ 64.94B
Total Debt¥ 9.29B¥ 11.88B¥ 8.72B¥ 4.89B¥ 3.44B
Net Debt¥ 8.34B¥ 9.68B¥ 5.99B¥ 1.28B¥ -945.00M
Total Liabilities¥ 20.35B¥ 25.93B¥ 25.44B¥ 19.58B¥ 17.26B
Stockholders' Equity¥ 52.89B¥ 52.00B¥ 52.07B¥ 50.67B¥ 47.31B
Cash Flow
Free Cash Flow¥ 5.53B¥ -957.00M¥ -1.04B¥ -1.35B¥ -257.00M
Operating Cash Flow¥ 9.38B¥ 5.90B¥ 5.18B¥ 4.16B¥ 4.37B
Investing Cash Flow¥ -4.39B¥ -7.37B¥ -5.93B¥ -5.57B¥ -4.33B
Financing Cash Flow¥ -6.29B¥ 1.00B¥ -183.00M¥ 616.00M¥ 921.00M
Currency in JPY

Daito Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Daito Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Daito Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Daito Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >